EFX vs SANA · P/E 54, rev $3.35B vs $846.0M cap
Equifax Inc (EFX) versus Sana Biotechnology Inc (SANA) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Sana Biotechnology Inc (SANA) is a biotechnology company listed on NASDAQ.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
SANA does not have a complete income-statement cache yet.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. SANA currently screens at market cap $846.0M.
Not investment advice. Open the EFX and SANA stock pages for the full models.
Not investment advice.